RxDoctor Payments Data

Cristina Bailey, MD

Family Medicine · Temecula, CANPI 1598715823

Payments from drug & device makers

$822in general payments, 2019–2025

Across 38 payments — averaging $21.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$195
  • Abbott$148
  • Baxter Healthcare$109
  • AbbVie$65
  • AstraZeneca$52
  • Hologic Sales And Service, LLC$45
  • plus $208 from 8 others

What the payments were for

  • Food & beverage$71387%
  • Other$10913%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$822 in reported general payments places this provider in the 70th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$29,968
Medicare patients
119
Services billed
2,334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban119$110,157
JanuviaSitagliptin Phosphate32$36,845
CreonLipase/Protease/Amylase14$28,910
OzempicSemaglutide30$28,233
XareltoRivaroxaban15$21,931
RybelsusSemaglutide17$18,413
TrulicityDulaglutide16$16,044
MounjaroTirzepatide14$13,950
JardianceEmpagliflozin12$12,142
Spiriva RespimatTiotropium Bromide18$8,993
Atorvastatin Calcium692$6,841
PremarinEstrogens, Conjugated20$6,598
JanumetSitagliptin Phos/Metformin Hcl12$6,256
Breo ElliptaFluticasone/Vilanterol14$5,535
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$5,015

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$13$116,756139 claims
Novo NordiskOzempic, Rybelsus$195$46,64647 claims
Lilly USA, LLCTrulicity, Mounjaro$40$29,99330 claims
AbbVieCreon$65$28,91014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,533 family medicine providers in California.

Other family medicine in Temecula

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →